【康臣药业(01681.HK)发布中期业绩 股东应占溢利4.98亿元 同比增加24.6% 皇牌产品尿毒清维持市场领先地位】智通财经APP讯，康臣药业(01681.HK)发布截至2025年6月30日止6个月业绩，该集团期内取得收入15.69亿元(人民币，单位下同)，同比增加23.7%;公司权益股东应占溢利4.98亿元，同比增加24.6%;每股基本盈利0.59元;拟派发中期股息每股0.33元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.